Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
nanoComposix
San Diego, California, United Statesnanocomposix.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
nanoComposix provides GMP/ISO13485-certified nanomaterial manufacturing and custom development services for a wide range of life science applications. Their products are used in preclinical research, diagnostics, drug delivery systems, and emerging nanomedicine projects. They do not appear to have proprietary drugs in clinical trials but enable client programs with their technology.
- Therapeutic areas
- OncologyDermatologyOther
- Modalities
- NanoparticleDevice (for diagnostic assays)Polymer-drug conjugate therapy (via polymer nanoparticles)Lipid nanoparticle delivery therapy (via lipid nanoparticles)Silica nanoparticle delivery therapy (via silica nanoparticles)
- Industry
- Chemicals & Materials
02
Partnerships
not publicly disclosed; works with numerous pharma/life science companies as a CDMO/service provider
Beyond the preview
Go deeper on nanoComposix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on nanoComposix.